Try our Advanced Search for more refined results
Portola Pharmaceuticals Inc.
-
Order | Filed: January 02, 2024 | Entered: January 02, 2024 In Re: Xarelto (Rivaroxaban) Products Liability Litigation
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability | Louisiana Eastern
Order
CONDITIONAL REMAND ORDER: ORDERED that the action(s) on this conditional remand order be remanded to its/their respective transferor court(s). Signed by Clerk of MDL Panel(Reference: 21-2240)(my) (NEF:JPML)
-
Order | Filed: December 20, 2023 | Entered: December 20, 2023 In Re: Xarelto (Rivaroxaban) Products Liability Litigation
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability | Louisiana Eastern
Order
SUGGESTION OF REMAND, OPINION, AND ORDER: The Court SUGGESTS that Sophie Hu et al. v. Janssen Pharmaceuticals et al., No. 21-002240, be remanded to the transferor court for further proceedings. Signed by Judge Eldon E. Fallon on 12/20/2023.(Reference: 21-2240)(NEF:JPML)(my)
-
Order | Filed: December 15, 2023 | Entered: December 15, 2023 Hayden v. Portola Pharmaceuticals, Inc. et al
Securities/Commodities | California Northern
Order ~Util - Terminate Motions ~Util - Set Deadlines/Hearings
Order by Judge Vince Chhabria granting 267 Motion for Disbursement of Funds. (vclc1, COURT STAFF) (Filed on 12/15/2023)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login